Literature DB >> 1583511

Development of prognostic index for primary supratentorial intracerebral tumours.

J L Hutton1, D F Smith, D Sandemann, P M Foy, M D Shaw, I R Williams, D W Chadwick.   

Abstract

The clinical course of intrinsic supratentorial tumours is variable. Prediction of outcome would be useful in defining patients for specific treatment policies. A retrospective analysis of 560 patients with intrinsic supratentorial tumours was performed. Proportional hazards models for survival were derived by using a stepwise selection procedure with only clinical and CT features as possible explanatory variables. The variables of prognostic importance were age, a first symptom of epilepsy, focal signs at presentation, a cystic lesion on CT scan, and duration of symptoms before presentation. The model defined a group with a good prognosis (score less than or equal to 9, n = 211) and a group with a poor prognosis (score greater than 9, n = 344). The median survival was 27 months for those with a score less than or equal to 9 or less and three months for those with score greater than 9. An alternative model, not including duration of symptoms, is also capable of defining groups with long (score less than or equal to 16, n = 234) and short (score greater than 16, n = 325) survival. The model may provide a means of classifying patients for inclusion in prospective randomised studies.

Entities:  

Mesh:

Year:  1992        PMID: 1583511      PMCID: PMC489038          DOI: 10.1136/jnnp.55.4.271

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  10 in total

1.  Low-grade gliomas: to treat or not to treat? A radiation oncologist's viewpoint.

Authors:  E G Shaw
Journal:  Arch Neurol       Date:  1990-10

2.  Differences between neurological and neurosurgical approaches in the management of malignant brain tumours.

Authors:  S J Wroe; P M Foy; M D Shaw; I R Williams; D W Chadwick; C West; G Towns
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-18

3.  Postoperative irradiation of glioblastomas. Results in a randomized series.

Authors:  A P Andersen
Journal:  Acta Radiol Oncol Radiat Phys Biol       Date:  1978

4.  Low-grade glioma. To treat or not to treat?

Authors:  J G Cairncross; N J Laperriere
Journal:  Arch Neurol       Date:  1989-11

5.  The management of patients with an intrinsic supratentorial brain tumour.

Authors:  D R Sandeman; A P Sandeman; P Buxton; H H Hughes; D W Chadwick; I R Williams; R D Baker; P M Foy; D M Shaw
Journal:  Br J Neurosurg       Date:  1990       Impact factor: 1.596

6.  A plain man's guide to the proportional hazards model.

Authors:  R Tibshirani
Journal:  Clin Invest Med       Date:  1982       Impact factor: 0.825

7.  Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group.

Authors:  K Kristiansen; S Hagen; T Kollevold; A Torvik; I Holme; R Nesbakken; R Hatlevoll; M Lindgren; A Brun; S Lindgren; G Notter; A P Andersen; K Elgen
Journal:  Cancer       Date:  1981-02-15       Impact factor: 6.860

8.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Authors:  M D Walker; S B Green; D P Byar; E Alexander; U Batzdorf; W H Brooks; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; G Owens; J Ransohoff; J T Robertson; W R Shapiro; K R Smith; C B Wilson; T A Strike
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

9.  Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres.

Authors:  E R Laws; W F Taylor; M B Clifton; H Okazaki
Journal:  J Neurosurg       Date:  1984-10       Impact factor: 5.115

10.  The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management.

Authors:  D F Smith; J L Hutton; D Sandemann; P M Foy; M D Shaw; I R Williams; D W Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-10       Impact factor: 10.154

  10 in total
  5 in total

1.  Prognostic significance of CT contrast enhancement within histological subgroups of intracranial glioma.

Authors:  K Lote; T Egeland; B Hager; K Skullerud; H Hirschberg
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

2.  Malignant cerebral glioma--I: Survival, disability, and morbidity after radiotherapy.

Authors:  E Davies; C Clarke; A Hopkins
Journal:  BMJ       Date:  1996-12-14

Review 3.  Effect of age on treatment decisions in low-grade glioma.

Authors:  C J Vecht
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-12       Impact factor: 10.154

4.  Prospective evaluation of a prognostic index for intrinsic supratentorial tumours.

Authors:  J L Hutton; D F Smith; D W Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-07       Impact factor: 10.154

5.  The prognostic influence of bcl-2 in malignant glioma.

Authors:  F E McDonald; J W Ironside; A Gregor; B Wyatt; M Stewart; R Rye; J Adams; H W W Potts
Journal:  Br J Cancer       Date:  2002-06-17       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.